🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Tenet Healthcare (THC) Shuffles Top Brass: What To Expect?

Published 08/31/2017, 10:01 PM
Updated 07/09/2023, 06:31 AM
AAPL
-
THC
-
HCA
-
UHS
-
CYH
-

Tenet Healthcare Corporation (NYSE:THC) has announced that its chairman and CEO Trevor Fetter will quit his position of director and chief executive officer. This will be effective Mar 15, 2018, or earlier when the company finds a suitable replacement.

Though Mr. Fetter will remain in his role, he will not be regarded as the most senior official.

Among other changes, the company has appointed the current independent lead director Ronald A. Rittenmeyer as the executive chairman, effective immediately. He will also be regarded as the senior most official at the company till the new CEO holds reins.
The company’s board composition will also be reviewed to sharpen management’s expertise in areas required for its long-term growth.

The company has also implemented shareholder rights plan to protect net operating losses which were $1.7 billion as of Dec 31, 2016. This implies that the company will be able to save $600 million in tax at a 35% tax rate.

This change in Tenet Healthcare’s leadership position comes at a time when it is in rough waters. The company’s results have been suffering from a decline in admissions, inpatient and outpatient surgeries, emergency department visits and total outpatient visits.

This also caused the company to post loss in last two quarters and miss earnings estimates in three quarters in a row prior to that.

Tenet Healthcare has also reduced its earnings guidance for 2017 after lackluster performance in first-half 2017.

The stock has given a poor performance in past one year as evident by a loss of 29.1% compared with the industry’s loss of 4.2%.

We believe it will be no mean task for the new leader to restore the company’s profitability. Though on a company-specific level, assets sales by management will help it to reduce high leverage but its top line will continue to be troubled by weak volume trends expected to continue throughout the industry.

The hospital industry is suffering from low patient admissions as they are increasingly choosing to stay away from hospitals due to high out-of-pocket (which shift the initial costs to patients) costs. Also, a pullback of insurers from public exchanges has increased the uninsured rate which in turn is hurting the company. Given the continued uncertainty about the future of Obamacare, the present scenario is likely to continue in the quarters ahead which will drain the company’s business volumes.

Other players in the industry like HCA Healthcare, Inc. (NYSE:HCA) , Community Health Systems Inc. (NYSE:CYH) , United Health Services, Inc. (NYSE:UHS) have been suffering from the industry weakness.

HCA Healthcare and Universal Health missed the second-quarter earnings estimates and cut their 2017 earnings guidance. Community Health on the other hand posted loss in the second quarter and reduced its 2017 earnings guidance.

Tenet Healthcare carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



Universal Health Services, Inc. (UHS): Free Stock Analysis Report

Tenet Healthcare Corporation (THC): Free Stock Analysis Report

Community Health Systems, Inc. (CYH): Free Stock Analysis Report

HCA Holdings, Inc. (HCA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.